To delineate the role of specific members of ␤ 1 integrins in stress erythropoiesis in the adult, we compared the response to phenylhydrazine stress in 3 genetically deficient models. The survival of ␤ 1conditionally deficient mice after phenylhydrazine is severely compromised because of their inability to mount a successful life saving splenic erythroid response, a phenotype reproduced in ␤ 1 ⌬/⌬ reconstituted animals. The response of bone marrow to phenylhydrazine-induced stress was, unlike that of spleen, appropriate in terms of progenitor cell expansion and mobilization to peripheral blood although late differentiation defects qualitatively similar to those in spleen were present in bone marrow. In contrast to ␤ 1 -deficient mice, ␣ 4 ⌬/⌬ mice showed only a kinetic delay in recovery and similar to ␤ 1 ⌬/⌬ , terminal maturation defects in both bone marrow and spleen, which were not present in VCAM-1 ⌬/⌬ mice. Convergence of information from these comparative studies lends new insight to the distinct in vivo roles of ␣ 4 and ␣ 5 integrins in erythroid stress, suggesting that the presence of mainly ␣ 5 ␤ 1 integrin in all hematopoietic progenitor cells interacting with splenic microenvironmental ligands/cells is instrumental for their survival and accumulation during hemolytic stress, whereas presence of ␣ 4, or of both ␣ 5 and ␣ 4 , is important for completion of terminal maturation steps. (Blood. 2011;117(3):975-985)
Introduction
During normal hematopoiesis, cells committed to specific lineages complete all their differentiation steps within hematopoietic tissues, and only the most mature cells are released into circulation. Thus, cues provided by the microenvironment (ME) in bone marrow (BM) or spleen, either through ligand/receptor interactions or through secreted cytokines and/or engagement of signaling molecules, are critical for lineage-committed cells and their differentiated descendants to complete their differentiation program. This interaction is uniquely exemplified in studies of erythroid lineage maturation. Close association of erythroid cells with cellular components of the ME seems to influence their differentiation; and among them, the macrophage (M) has received the most attention. Through physical contact with erythroid cells, Ms create a functionally interactive unit, the erythroblastic island (EI), which appears to exert major influence on later stages of erythroid differentiation/maturation. The EI was first described by Bessis et al, 1 but its functional influence was only recently analyzed by in vitro and in vivo approaches. Several proteins on the surface on Ms in partnership with proteins on erythroid cells appear to mediate these effects. [2] [3] [4] [5] [6] Furthermore, secreted M proteins, like Gas6, seem to interact with their cognate receptors present in erythroid cells enhancing integrin-dependent binding. 7 Whether these proteins have a redundant function or work in complexes cooperating with each other, or become functional at different stages of differentiation and under different conditions in vivo, is presently unclear.
In addition to erythroid cell/M interactions within the EI, direct interactions of erythroid cells with extracellular matrix components, like fibronectin, have been implicated in the regulation of erythropoiesis. The presence of fibronectin counterreceptors on erythroid cells, 8 like members of the beta 1 integrins (␣ 4 ␤ 1 and ␣ 5 ␤ 1 ), is thought to mediate these interactions. Both ␣ 4 and ␣ 5 integrins are widely expressed in hematopoietic cells and have been implicated in several functional aspects, such as proliferation, survival, maturation of erythroid cells, or in homing and proliferation of hematopoietic progenitor cells. [9] [10] [11] [12] [13] [14] [15] However, in vitro and in vivo data have not been consistent, so that the exact role of these 2 integrins has remained inconclusive. For example, adhesion to fibronectin is dependent on both ␣ 4 ␤ 1 and ␣ 5 ␤ 1 , and it was found to influence stem cell homing of hematopoietic progenitors to BM or spleen, but the results have been controversial for ␣ 5 integrin. 8, 11, 14 Other in vitro experiments comparing effects of ␣ 4 and ␣ 5 have shown that only ␣ 4 ␤ 1 , not ␣ 5 ␤ 1, influences proliferation and protection from apoptosis of erythroid cells, 16 whereas opposite conclusions were reached by others, 17 or effects were selective for BM and not spleen. 18 Yet, genetic deletion of all ␤ 1 integrins showed no effects on erythroid differentiation, only effects on colonization of hematopoietic tissues during development (fetal liver, spleen, and BM) 19 and no effects on baseline or stress erythropoiesis in ␤ 1 -conditionally deleted adult animals. 20 Thus, the ␤ 1 genetic data are in contrast with differentiation defects described for fetal erythroblasts in ␣ 4 ␤ 1 knockout mutants 21 and in ␣ 4 chimeras, 22 or with impairment of stress hematopoiesis/erythropoiesis in adult animals with ␣ 4 conditional deletion. 23 These diverse and controversial data have been difficult to reconcile and prompted us to reexamine the phenotype of ␤ 1 conditionally deleted mice and compare them to ␣ 4 or VCAM-1 deleted mice under conditions of stress.
Our data dissecting the influence exerted by ␣ 4 versus ␣ 5 integrins in response to erythroid stress provide novel information on the role of ␤ 1 integrins in erythropoiesis. Their effects are distinctly manifested in different hematopoietic environments (ie, BM vs spleen) and seem to be directed at discreet stages of erythroid differentiation. Further, transplantation experiments have indicated that the great majority of the effects seen in ␤ 1 ⌬/⌬ animals are, by and large, hematopoietic cell autonomous, but as yet undefined effects from a ␤ 1 -deficient ME may provide contributory function.
Methods

Mice and treatment
MxCreϩ␤ 1 f/f mice were obtained in our laboratory by breeding ␤ 1 f/f mice 24 with MxCre ϩ transgenic mice (both from The Jackson Laboratory). ␤ 1 integrin deletion was induced by 6 intraperitoneal injections of polyriboinosinic acid/ polyribocytidylic acid (Sigma-Aldrich), and mice were used at least 4 weeks later. Polyriboinosinic acid/polyribocytidylic acid-treated Cre-negative littermates served as controls. ␣ 4 integrin-deficient mice were generated in our laboratory. 23, 25 VCAM-1-deficient mice were described previously. 26 To induce acute anemia, mice were injected with phenylhydrazine (PHZ; Sigma-Aldrich) at 60 mg/kg intraperitoneally on 2 consecutive days. Peripheral blood (PB) parameters were determined using a HEMAVET950 (Drew Scientific). To study the role of macrophages, mice received a single intravenous injection of 200 L of clodronate-loaded or empty liposomes. Animals were housed at the University of Washington Comparative Medicine Specific Pathogen-Free Vivarium, with irradiated chow and autoclaved water ad libitum. All procedures were done according to protocols approved by the University of Washington Institutional Animal Care and Use Committee.
Transplantation B6 ϫ 129.F1 mice (The Jackson Laboratory) were used as recipients. Mice were lethally irradiated (1150 cGy) and injected intravenously with 0.25 ϫ 10 6 (for colony-forming unit-spleen [CFU-S]) or 10 ϫ 10 6 ␤ 1 ⌬/⌬ or ␣ 4 ⌬/⌬ BM cells for long-term repopulation. In the latter, after complete reconstitution of hematopoiesis, acute hemolytic anemia (PHZ) was induced. Mice reconstituted with wild-type ␤ 1 ϩ or ␣ 4 ϩ/ϩ BM cells served as controls.
FACS analysis
To study integrin expression in cells from PB, BM, and spleen at steady state or after PHZ treatment, we used the following antibodies: CD44, CD45, ␤ 1 , ␣ 2 , ␣ 5 , ␣ 4 ␤ 7 , active caspase (BD Biosciences), ␣ 4 (Southern Biotechnology), ␣ 6 , F4/80 (AbD Serotec), and ␣ 9 (R&D Systems) and analyzed by fluorescence-activated cell sorting (FACS).
CFU-C assay
The committed progenitors of all lineages, colony-forming unit-colony (CFU-C), were assessed in methylcellulose cultures. 26 For "stress" burstforming units-erythroid (BFU-E) in spleen, the cells were cultured in the presence of erythropoietin (Epo) only. 27, 28 All colony types were counted at day 7, except for CFU-E, which were counted on day 3.
Homing in spleens of nonirradiated recipients
Nonirradiated wild-type (␣ 4 ϩ/ϩ , ␤ 1 ϩ/ϩ ) mice were injected with 20 ϫ 10 6 control (␣4 f/f , ␤ 1 f/f ) or ␤ 1 ⌬/⌬ BM cells and were killed 24 hours later (supplemental Figure 3 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Integrin expression and hematopoiesis in ␤1 ⌬/⌬ at steady state. (A) Expression of various integrins in CD45 ϩ BM cells of ␤1-deficient (␤1⌬, thick black line) or ␤1-sufficient, control (␤1 ϩ , gray histogram) mice; isotypematched control is represented by a thin dotted line. Note that the expression of ␣4␤7 is up-regulated in ␤1 ⌬/⌬ BM cells. (B) Lin Ϫ , Sca-1 ϩ , c-kit ϩ (LSK) cells in the femurs of control (n ϭ 10) and ␤1 ⌬/⌬ (n ϭ 15) mice. (C) Cells and progenitors per femur, spleen, and 1 mL of PB in ␤1 ⌬/⌬ (BM, n ϭ 19; spleen, n ϭ 13; PB, n ϭ 17) or control, ␤1 ϩ (BM, n ϭ 18; spleen, n ϭ 6; PB, n ϭ 17) mice. White bars represent control mice; and gray bars, ␤1 ⌬/⌬ mice. *Significant difference over control (P Ͻ .05). (D) ␣4 versus ␣5 expression in ␤1 ⌬/⌬ spleen cells compared with ␣4 ⌬/⌬ mice or control mice. (E) Relative expression of ␣4 and ␣5 integrin in erythroid cells (TER119 ϩ ) at progressive maturation stages: R1, CD71 hi /TER119 lo (gray shaded area); R2, CD71 hi /TER119 hi (white area with bold line); and R3, CD71 lo /TER119 hi (white area with thin, dotted line). Note the higher ␣5 expression in early R1 erythroblasts (gray).
CFU-S assay
Information on CFU-S assay is contained in Figure 5 .
Adhesion to spleen sections in vitro
Information on adhesion to spleen sections in vitro is contained in supplemental Figure 4 .
Immunohistochemistry
Bones and spleens fixed with 4% paraformaldehyde were treated as previously described. 29, 30 Frozen sections were labeled with anti-CD31 (MEC, 13.3) and anti-CD29 (9EG7, BD Biosciences, and MB1.2, Chemicon/ Millipore), anti-bone morphogenetic protein 4 (BMP4; ab 39973, Abcam), anti-CD68 (FA-11, AbD Serotec), and F4/80 (CI:A3-1, Fitzgerald Industries International) and visualized with 2°Alexa 594-conjugated fluorochromes (Invitrogen).
BMP4 quantitative reverse-transcribed polymerase chain reaction
Total RNA was isolated from the spleens of control and ␤ 1 ⌬/⌬ mice treated with PHZ (d4) and reverse-transcribed using random primers. Obtained cDNA was used in quantitative polymerase chain reaction with primer sets for BMP4 (F-ctcccaagaatcatggactg, R-aaagcagagctctcactggt) and b-actin (F-atcctcaccctgaagtaccc, R-atttcccgctcggccgtggt).
Results
Genetic models
MxCre؉␤ 1 f/f (␤ 1 ⌬/⌬ ) mice. Generation of these mice has been previously described, 24 although a detailed evaluation of their erythropoiesis and expression of different ␤ 1 heterodimers in hematopoietic tissues have not been presented. Partial expression data were also presented in a similar ␤ 1 conditional model. 31 Ablation of ␤ 1 in BM cells was more than 95% (95.5% Ϯ 0.84%, n ϭ 16). Specific ␤ 1 integrin heterodimer expression is shown in Figure 1A . Drastic reduction in ␣ 5 ␤ 1 expression is seen, whereas other dimers, like ␣ 4 and ␣ 6 , are well expressed, probably because of their association with alternate ␤ 1 partners (␣ 4 ␤ 7 or ␣ 6 ␤ 3 ). Overall dramatic differences in the 2 most abundant integrins, ␣ 4 , splenic weight (ctrl, n ϭ 25; ␤1 ⌬/⌬ , n ϭ 6), and splenic cellularity (ctrl, n ϭ 25; ␤1 ⌬/⌬ , n ϭ 6). (B) Erythroid differentiation in BM and spleen. FACS profiles of CD71/TER119-labeled splenic cells (left panels in BM and spleen), and CD44/side scatter analysis of TER119 ϩ cells from days 0 and 6 after PHZ (right panels in BM and spleen). Note the failure of ␤1 ⌬/⌬ erythroid cells to advance to later maturation stages (ie, from R1 to R2 in the CD71/TER119 profiles after RBC lysis). CD44/side scatter analysis of TER119 ϩ cells shows discreet stages of progressive maturation (from I-V) before PHZ but a significant overlap after PHZ treatment in both sets of animals. (C) Progenitors (total CFU-C, left panel; BFU-E/stress BFU-E, middle panel; and CFU-E, right panel) in spleen before and after PHZ treatment in controls and ␤1-deficient mice. (Stress BFU-E are shown as a proportion of total BFU-E.) Note the significant reduction of all progenitors in spleen after PHZ treatment in ␤ 1 ⌬/⌬ mice (day 6). and ␣ 5 , were seen in BM hematopoietic cells of these mice. Integrin ␣ 5 was virtually absent in all BM cells, but ␣ 4 was expressed at high levels, with a significant overexpression of ␣ 4 ␤ 7 . 32 Cellularity in hematopoietic tissues (BM, spleen) was normal to increased in ␤ 1 mice ( Figure 1B -C left panel). Significant differences in progenitor content were present in both BM and PB; however, no significant differences were recorded in the spleen ( Figure 1C right panel). Hematocrit and hemoglobin levels were not statistically different from controls, but platelets were higher in ␤ 1 mice (P Ͻ .05).
Tie2Cre؉␣4 f/f (␣4 ⌬/⌬ ) mice. These mice have been described in detail in several prior publications. 23, 25 Differences in the expression of ␣ 4 and ␣ 5 integrins in ␤ 1 ⌬/⌬ and ␣ 4 ⌬/⌬ spleens are shown in Figure 1D . Of particular note is the fact that the abundance of ␣ 4 and ␣ 5 in erythroid cells is different at progressing differentiation stages: ␣ 5 expression is higher in earlier cells, 8 whereas ␣ 4 is widely expressed throughout nucleated erythroid cells ( Figure 1E ).
Tie2Cre؉/VCAM-1 f/f (VCAM-1 ⌬/⌬ ) mice. The phenotype of these mice has been described by us and others. 26, 33, 34 VCAM-1 represents the major and preferred ligand for ␣ 4 ␤ 1 integrin in endothelial cells and also binds ␣ 9 ␤ 1 . These mice share many functional phenotypic features with ␣ 4 ⌬/⌬ mice, but there have also been distinct differences. 26, 34 Overall, the aforementioned 3 models are characterized by normal basal erythropoiesis but display different integrins in their erythroid cells, and their functional responses to erythroid stress have not been studied in detail before.
Erythroid response and survival of ␤ 1 ⌬/⌬ mice is critically impaired after PHZ stress
Both ␤ 1 ⌬/⌬ and control mice received 2 injections of PHZ and were studied at days 4 and 6 after the first injection. All control mice survived the hemolytic challenge, but half of the ␤ 1 ⌬/⌬ mice died by day 6 (Figure 2A ). Hematocrit levels reached a nadir in control animals 2 days after the last injection (day 4) and began to recover from that point on. ␤ 1 ⌬/⌬ mice had similar initial and nadir hematocrit levels, but in contrast to controls, hematocrit levels continued to drop (supplemental Figure 1 ). Dramatic differences between controls and ␤ 1 ⌬/⌬ mice were seen when splenic weights and cellularities were compared at days 4 and 6 ( Figure 2A ).
To further explore differences between control and ␤ 1 ⌬/⌬ mice after PHZ, detailed studies on spleen cell populations, differentiation of erythroid cells, and progenitor cell content were carried out (Figures 2-4 ). TER119 ϩ erythroid cells were analyzed by FACS using coexpression with CD71 35 or CD44. 36 Immature cells, especially R1 ( Figures 2B, 3 ), outnumbered the more mature types (R1:R2 ratio at day 6 was 1:8 in controls vs 1:0.4 in ␤ 1 ⌬/⌬ ) and all subsets of erythroid cells in spleen were diminished compared with controls ( Figure 4 top panels; supplemental Figure 2 ). Not only were erythroid cells very low in ␤ 1 ⌬/⌬ spleen, but also progenitor cells of all classes ( Figure 2C ). Specifically BFU-E, "stress" BFU-E and CFU-E were all drastically diminished ( Figure 2C ). Importantly, there was an increased proportion of apoptotic cells in total splenocytes and in CD71 ϩ /TER119 ϩ cells by activated caspase-3 evaluation ( Figure 5A-B) .
In contrast to spleen, BM revealed a different picture in which both cellularity and total CFU-C content were no different between controls and ␤ 1 ⌬/⌬ mice ( Figure 4 ). However, erythroid cells, albeit sufficient in numbers, exhibited a deficiency toward more mature cell numbers, so that, as in spleen, immature erythroid cells outnumbered their mature counterparts, suggesting a differentiation/ maturation deficit ( Figure 4 upper and middle right panels; supplemental Figure 2 ). The proportion of active caspase-3 ϩ / TER119 ϩ cells in spleen was significantly increased over controls but to a lesser degree in BM ( Figure 5B ). Of interest, there was also an increase in circulating progenitor cells after PHZ in both sets of animals, but ␤ 1 -deficient mice had much higher numbers, including BFU-E and CFU-E, suggesting no impairment in generating BM progenitors in ␤ 1 ⌬/⌬ mice ( Table 1) .
Inability of ␤ 1 ⌬/⌬ mice to respond to hemolytic stress is largely cell autonomous
To test whether the lack of splenic response to PHZ challenge was dependent on environmental cells in the spleen or only on the absence of ␤ 1 integrin in hematopoietic cells, we compared responses of nontransplanted ␤ 1 ⌬/⌬ mice to irradiated wild-type recipient mice reconstituted with ␤ 1 ⌬/⌬ donor cells. Transplanted controls were wild-type mice reconstituted with normal cells. Approximately 8 weeks after transplantation, after verification that the phenotype of PB cells was as expected (ie, in either ␤ 1 ϩ or ␤ 1 ⌬/⌬ ; data not shown), all transplanted mice were subjected to PHZ challenge. As seen in Figure 4 , the spleens of mice reconstituted with ␤ 1 ⌬/⌬ cells not only failed to respond as the transplanted controls, but the same pattern of differentiation failure as in nontransplanted ␤ 1 ⌬/⌬ mice was seen ( Figure 4 right top panel). . Inability of ␤1 ⌬/⌬ mice to respond to hemolytic stress is largely cell autonomous. Lethally irradiated wild-type recipients were reconstituted with ␤1 ⌬/⌬ or ␤1 ϩ BM cells and after reconstitution were treated with PHZ to induce acute hemolytic anemia. Six days after the first PHZ injection, mice were killed, and cellularity, progenitor content, and erythroid differentiation (number of TER119/CD71 ϩ cells in gates R1 [CD71 hi /TER119 lo ], R2 [CD71 hi /TER119 hi ], and R3 [CD71 lo /TER119 hi ]) were assessed in the spleen (top panel) and BM (middle panel). Transplanted (Tx) mice (ctrl, n ϭ 6; and ␤1 ⌬/⌬ , n ϭ 6) were compared with corresponding nontransplanted counterparts. *Significant difference over the respective ␤1 ϩ control group. Cross-hatched bars represent transplanted; and white bars, nontransplanted. P Ͻ .05. #Significant difference over nontransplanted counterparts (P Ͻ .05). Note that transplanted ␤1 ⌬/⌬ mice (black bars) have a similar response to PHZ as nontransplanted ␤1 ⌬/⌬ mice (gray bars). The bottom panel shows the difference in spleen sizes of 2 control-transplanted mice (ϩ/ϩ recipients transplanted with ϩ/ϩ donor cells) after PHZ treatment at day 6 (left), compared with 2 ␤1 ⌬/⌬ -transplanted mice (ϩ/ϩ recipients transplanted with ␤1 ⌬/⌬ cells, right). Spleens were photographed with a Nikon Coolpix 995 camera next to a ruler measuring millimeters.
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For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Some notable differences were present: the splenic weight (122 Ϯ 12 g in nontransplanted ␤ 1 ⌬/⌬ mice, n ϭ 6 vs 168 Ϯ 15 g in wild-type recipient mice reconstituted with ␤ 1 ⌬/⌬ donor cells, n ϭ 5) and total number of R1 cells in spleen were higher in ␤ 1 ⌬/⌬ reconstituted versus nontransplanted ␤ 1 ⌬/⌬ mice (Figure 4 upper panel). However, the erythroid cells in the recipients of ␤ 1 ⌬/⌬ cells, in both BM and spleen, showed the same differentiative defect as the nontransplanted ␤ 1 ⌬/⌬ mice (Figure 4 upper and middle panels). These data suggest that recipients of ␤ 1 ⌬/⌬ cells do generate a few more TER119 ϩ cells than the nontransplanted mice but display the same overall phenotypic response.
The modest quantitative differences between mice reconstituted with ␤ 1 ⌬/⌬ cells and nontransplanted ␤ 1 ⌬/⌬ mice would suggest an ameliorating effect of the normal splenic environment in the former Figure 5 . Apoptosis levels in ␤1 ⌬/⌬ cells in BM and spleen after PHZ treatment and the ability of ␤1 ⌬/⌬ cells to home and form CFU-S. (A) Expression of activated caspase-3, an apoptosis marker, in the spleens of control and ␤1 ⌬/⌬ mice. A significant proportion of apoptotic cells among splenocytes of ␤1 ⌬/⌬ mice was noted after PHZ treatment. In contrast to ␤1 ⌬/⌬ mice, no difference in apoptosis in spleen between control and ␣4 ⌬/⌬ mice after PHZ treatment at day 4 was detected (data not shown). (B) Cells from BM and spleen of PHZ-treated (day 4) mice were put into in vitro culture made up of Iscove modified Dulbecco medium supplemented with 10% fetal bovine serum, L-glutamine, penicillin, and streptomycin containing cytokines (3 U/mL recombinant human Epo, 50 ng/mL recombinant murine stem cell factor, 10 ng/mL recombinant murine interleukin-6, and 10 ng/mL recombinant murine interleukin-3). Two days later, cells were washed, resuspended in the just described medium without the cytokines, and 6 hours later were taken for analysis. Caspase-3 expression in TER119 hi /CD71 hi cells is shown before (day 0) and after (day 2) in vitro incubation with cytokines and after cytokine withdrawal (6 hours). Note that in ␤1 ⌬/⌬ mice, even at the initial time point, there is a difference in the level of apoptosis between BM and spleen, and this is exaggerated on cytokine deprivation. (C) Homing into nonirradiated recipients: Wild-type mice were injected with control (␤1 ϩ , n ϭ 5 recipient mice) or ␤1-deficient (␤1 ⌬/⌬ , n ϭ 5 recipient mice) BM cells. Twenty-four hours later, recipients were killed and spleen cells were plated in methylcellulose cultures. Individually plucked colonies were genotyped (supplemental Figure 3) to determine the origin of the host (␣4 ϩ/ϩ , ␤1 ϩ/ϩ ) or donor (␤1 f/f , ␣4 f/f , or ␤1 ⌬/⌬ ) colonies and proportion of homed progenitors. The number of assessed colonies is shown above the bars. (D and bottom panels) CFU-S assessment: Lethally irradiated wild-type recipients were injected with 250 000 control (␤1 f/f , ␣4 f/f ) or integrin-deficient (␤1 ⌬/⌬ , ␣4 ⌬/⌬ ) BM cells (5 recipients per group). Eleven days after transplantation, recipients were killed, spleens were harvested, fixed in Bouin solution, and macroscopic colonies under the spleen capsule were counted using a Nikon MZ6 dissecting microscope. The number of large colonies per spleen is shown. Appearance of CFU-S in recipients of control and integrin-deficient cells is also shown (lower panels). ␤1 ⌬/⌬ mice have fewer CFU-S than controls, whereas ␣4 ⌬/⌬ mice have more but usually of smaller size. Spleens were photographed in a 35-mm Petri dish with a Nikon Coolpix 995 camera. Images were uploaded to a computer and adjusted for brightness and contrast with Adobe Photoshop. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From group. Ideally, the reverse transplantation (ie, normal [␤ 1 ϩ ] cells into ␤ 1 ⌬/⌬ recipients) would test this issue. However, this type of experiment is not practically feasible because of the poor health (nonhematopoietically related) of ␤ 1 ⌬/⌬ animals exacerbated by the toxicity of irradiation. Instead, we used CFU-C in nonirradiated normal spleens ( Figure 5C ; supplemental Figure 3 ), which tests the ability of ␤ 1 ⌬/⌬ cells to settle in the nonirradiated environment of a normal spleen. In the second approach, the read-out of ␤ 1 ⌬/⌬derived CFU-S (size and colony number) in the irradiated normal spleen tests the ability of normally lodged ␤ 1 ⌬/⌬ progenitors to form CFU-S. The data from these experiments are presented in Figure  5D (bottom panels). It is evident from these experiments that the transient homing of ␤ 1 ⌬/⌬ progenitor cells to spleen is not impaired, but their subsequent development into CFU-S is impaired, suggesting a postlodgment defect in the expansion of ␤ 1 ⌬/⌬ progenitors in a normal splenic environment. Assuming a similar stress environment after irradiation and after PHZ, the data would suggest that ␤ 1 ⌬/⌬ cells cannot efficiently expand and differentiate in the erythroid stress environment of the normal spleen, consistent with the picture in ␤ 1 ⌬/⌬ transplanted mice. To provide an insight on the erythroid maturation defect, we tested the ability of both control and ␤ 1 ⌬/⌬ TER119 ϩ cells taken from spleens on day 6 after PHZ to adhere to control or ␤ 1 ⌬/⌬ spleen frozen sections. Normal erythroblasts adhere less to ␤ 1 ⌬/⌬ spleen than to normal spleen (294 Ϯ 23 adhered cells and 641 Ϯ 122 adhered cells, respectively, P Ͻ .05) and ␤ 1 ⌬/⌬ erythroblasts adhered, as expected, less to normal spleen (supplemental Figure 4B ). If adhesion is a requisite step for erythroid maturation, our data would suggest that the splenic environment or its altered architecture after PHZ in ␤ 1 ⌬/⌬ mice may fail to provide an additional support mechanism for proper red cell maturation. However, to what extent these in vitro adhesion-dependent data together with in vitro EI formation using ␤ 1 ⌬/⌬ or control Ms for attachment of erythroid cells (supplemental Figure 4C -D) reflects the in vivo picture is unclear.
Comparison of PHZ responses in ␤ 1 ⌬/⌬ , ␣ 4 ⌬/⌬ , and VCAM-1 ⌬ mouse models
Both ␣ 4 ␤ 1 and ␣ 5 ␤ 1 integrins have been implicated in proliferation of erythroid cells, and ␣ 4 integrin particularly has been considered a participant in EI interactions. 37 To characterize the in vivo effects of these integrins in adult hematopoiesis and avoid the use of antibody treatment, we compared the response to stress erythropoiesis among the 3 genetic models: ␤ 1 ⌬/⌬ mice with a deficiency primarily of ␣ 5 ␤ 1 in erythroid cells, ␣ 4 ⌬/⌬ mice lacking both ␣ 4 ␤ 1 and ␣ 4 ␤ 7 (the latter being overexpressed in ␤ 1 ⌬/⌬ mice), and VCAM-1 ⌬/⌬ mice lacking the major ligand of ␣ 4 integrin in ME cells. Survival and detailed spleen and BM responses were assessed in these models in a similar way as described earlier for ␤ 1 ⌬/⌬ mice.
Whereas occasional death was seen in ␣ 4 ⌬/⌬ mice after PHZ treatment, 90% of animals tested survived and responded to PHZ stress (supplemental Figure 1) . A transient deficit in progenitor content was seen at day 4 in both BM and spleens of ␣ 4 ⌬/⌬ compared with controls, but there was a quick recovery at day 6 and beyond ( Figure 6 ). By day 6 after PHZ treatment, their response in spleen was normal in cellularity, progenitor content, and total erythroid cells compared with their controls, unlike the response of ␤ 1 ⌬/⌬ mice ( Figure 6 ). However, a defect in maturation profile was evident in both spleen and BM of these mice ( Figure  6A-B right panels) . This was probably responsible for their delayed hematocrit response to PHZ (supplemental Figure 1 ) and alluded to in our earlier publication. 23 No differentiation defect was seen in the spleen or BM of VCAM-1 ⌬/⌬ mice, in contrast to the 2 other models ( Figure 6C ).
Overall, ␣ 4 ⌬/⌬ mice share the terminal maturation defects present in BM and spleen with ␤ 1 ⌬/⌬ mice. The data are supportive of the concept that ␣ 5 ␤ 1 exerts a critical influence on the accumulation and survival of hematopoietic progenitors in spleen (ie, on the Epo-dependent stage of erythroid cell differentiation), whereas ␣ 4 alone or together with ␣ 5 in ␤ 1 ⌬/⌬ mice influences the Epo-independent maturation stages of erythropoiesis.
ablation in nonhematopoietic cells
Dramatic differences in erythroid stress responses are seen in the spleen versus BM of both ␤ 1 ⌬/⌬ mice and mice transplanted with ␤ 1 ⌬/⌬ cells. To explain some of these differences, we tested whether differences in nonhematopoietic cell ␤ 1 ablation in these 2 tissues may be responsible for this outcome. Three candidate populations (fibroblasts, endothelial cells, and resident Ms) were tested for ␤ 1 ablation after polyriboinosinic acid/polyribocytidylic acid treatment. Efficient ablation in Ms, but only partial ablation in fibroblastic cells, was found (supplemental Figure 5) . The data for cells in spleen were similar.
To examine the expression of ␤ 1 integrin in endothelial cells in situ both in BM and spleen, we labeled them with anti-␤ 1 and with 9EG7, a monoclonal antibody reacting only with activated ␣ 4 ␤ 1 . 38 As seen in Figure 7 , endothelial cells in BM and spleen were similarly labeled in control and ␤ 1 ⌬/⌬ tissues. Megakaryocytes were labeled only in controls, not in ␤ 1 ⌬/⌬ , but were labeled in all mice with anti-CD31 (data not shown). Thus, among the 3 populations tested, we found no evidence for better ablation of ␤ 1 integrin in spleen versus BM to explain differences in response. Despite phenotypic similarities, however, it is possible that cells may behave differently in the 2 environments.
To further understand the mechanisms responsible for observed impairment in stress erythropoiesis in spleen, we assessed the expression of BMP4, a signaling molecule implicated in stress erythropoiesis 27, 28 and produced by stromal and hematopoietic cells. 39 By quantitative reverse-transcribed polymerase chain reaction (data not shown) and as supported by immunofluorescent staining, no gross differences in BMP4 expression were found in the spleens of ␤ 1 ⌬/⌬ versus control mice ( Figure 7I-J) . Furthermore, we assessed the role of Ms by treating mice with clodronate (supplemental Figure 6 ). Although the response of clodronatetreated animals to PHZ challenge was severely compromised (supplemental Figure 6 top panels) , the interpretation of these experiments is confounded by the effects of clodronate treatment in spleen beyond M purging (supplemental Figure 6 bottom panels).
Discussion
Studies using several genetic mutant mice have shown impaired responses to erythroid stress, although erythropoiesis is fairly normal at homeostasis (ie, ICAM, 3 Gas-6, 7 and Stat5a,b 35 Rac1/ 2). 18 Furthermore, in several models of stress erythropoiesis, impairment of response is observed in both BM and spleen or only in one of these tissues. For example, in the absence of the glucocorticoid receptor, erythropoiesis is compromised both in BM and spleen. 40 Yet, in other models (ie, in Rb null mice), prominent changes are seen only in the spleen. 41, 42 In contrast to Rb, the absence of Rac1/Rac2 signals leads to defective early erythropoiesis in BM, but in the spleen erythropoiesis is completed successfully, as the splenic environment apparently circumvents the need of Rac1/Rac2 in early erythropoiesis.
Our results with ␤ 1 ⌬/⌬ mice have some features in common to previously described mutant mice, but others appear to be unique to our model. Similar to Rb null mice 42 or the TRalpha null mice 43 and FAK Ϫ/Ϫ mice 44 and in sharp contrast to Rac1/Rac2-deficient mice, 18 defects in ␤ 1 ⌬/⌬ mice are prominent only in the spleen, leading to failure to survive stress ( Figure 2 ). Precise mechanistic differences between BM and spleen responses have not been explored in most of the cases, although several insights have been obtained. For example, it was previously shown that convergence of Sonic hedgehog (Shh), BMP4, and stem cell factor-dependent signaling in spleen is necessary for the development and expansion of BMP4-resposive stress erythroid progenitors. 27, 28 Thus, Smo ⌬/⌬ mice, 28 with absence of Shh signaling, do not recover from a second PHZ treatment, 28 resulting from failed splenic response.
In our ␤ 1 ⌬/⌬ mice, the generation of progenitor cells by BM and their egress to PB, which is necessary for subsequent colonization of the spleen as it occurs in normal animals, was not impaired ( Figure 4 ; Table 1 ). But why did these progenitors not accumulate in ␤ 1 ⌬/⌬ spleens? To explain these data, we entertained the following mechanistic scenarios An attractive possibility is that progenitors generated in BM and delivered to circulation, as shown by their increase in PB after PHZ (Table 1) , cannot home and/or cannot be firmly retained in the spleen if they lack ␤ 1 integrin. Such homing/retention properties may be dependent primarily on the presence of ␣ 5 ␤ 1 because in the other 2 related mutants (ie, the ␣ 4 ⌬/⌬ or VCAM-1 ⌬/⌬ mice in which fibronectin/␣ 5 interactions are present), homing of progenitors to spleen is not impaired. 23 Consistent with this concept, previous data with fetal liver ␤ 1 knockout cells have shown failure of BM and splenic colonization by fetal liver ␤ 1 null cells 45 ; and in another study, there was a small decrease in homing to irradiated spleen with anti-␣ 5 integrin antibody-treated donor cells. 15 However, our present data, showing no significant impairment of splenic homing in nonirradiated recipients given adult ablated ␤ 1 cells ( Figure 5 ; supplemental Figure 1 ), appear inconsistent with these data. In this context, it is important to emphasize that homing in some of the previous data was evaluated by successful engraftment (colonization), whereas in our studies we have dissociated homing/lodgment events from subsequent expansion/engraftment events with ␤ 1 ⌬/⌬ cells. Despite the normal homing, we found that the development of CFU-S was significantly impaired in ␤ 1 ⌬/⌬ mice as shown by the reduced number and size of CFU-S ( Figure 5 ), suggesting impairment in survival and/or expansion of homed progenitors. Thus, the absence of ␤ 1 signaling in the context of fibronectin-dependent interactions in the spleen has a profound impact on progenitor cell survival and proliferation. Activation of signaling pathways intersecting ␤ 1 integrin signaling 46 may promote expression of unique sets of genes responsible for cell proliferation/survival, and our data in ␤ 1 -decifient PHZ-treated spleens are consistent with this thesis.
The connection of ␤ 1 or ␣ 5 ␤ 1 signaling with survival and/or proliferation is supported by a host of previous data:
1. Fibronectin, and not VCAM-1, is the preferential ligand for cycling cells, and ␣ 5 integrin is up-regulated in cycling cells, in contrast to ␣ 4 , which is not different in cycling versus noncycling cells. 47 2. In vivo treatment of mice with C274, the RGD-dependent recombinant fibronectin, reduced splenic progenitor growth (HPP-CFC). 12 By contrast, treatment with CH296 fibronectin containing all binding sites, including the CS-1 VLA4 binding site, did not decrease splenic progenitors. 3. Donor cells treated with a rabbit anti-␤ 1 antibody resulted in reduced numbers of CFU-S in irradiated normal spleen. 48 4. Wv mutant mice, which have an impaired splenic response to stress after PHZ or after transplantation, are not able to activate ␣ 5 . 12 5. Impairment of ␤ 1 -dependent FAK in conditional mutant mice led to a picture of PHZ response similar to our ␤ 1 ⌬/⌬ mice with drastically reduced splenic response and decreased proliferation and survival of progenitor cells. 44 6. ␣ 5 ␤ 1 integrin influenced Shh signaling in intestinal epithelia proliferation, and the phenotypic changes of ␤ 1 deletion in intestinal epithelial cells were strikingly similar to mice with defective Shh expression or signaling. In aggregate, these findings, together with our own, support the concept of impaired survival and proliferation of ␣ 5 ␤ 1 -deficient progenitors in the stress splenic environment.
But why would an intrinsic defect like ␤ 1 -deficiency lead to impaired interactions selectively within the splenic environment? It is possible that in the spleen, in contrast to BM, retention and subsequent development of erythroid cells are mainly an Arg-Gly-Asp (RGD)-dependent process (RGD being the best known recognition sequence in fibronectin for ␣ 5 ␤ 1 integrin). This process will fail in ␤ 1 ⌬/⌬ mice in which erythroid cells lack ␣ 5 ␤ 1 . However, in BM other redundant signals on erythroid cells (ie, CD44, ␣ 4 ␤ 7 , and ␤ 7 integrin) can interact with environmental ligands unique to BM (ie, tenascin-C, laminin species, osteopontin, thrombospondin, syndecan-4, or heparan sulfate proteoglycans), 46, 49 and usurp or substitute for the RGD effects on developing erythroid cells. Furthermore, beyond RGD-dependent effects, it is possible that other ME cells or matrix in BM display distinct functional behavior compared with spleen. Such a functional difference could be attributed to differences in the efficiency of the ablation of ␤ 1 integrin between BM versus splenic stromal cells. We have obtained no evidence that cultured fibroblasts are better ablated in BM versus the spleen, whereas endothelial cells in both BM and spleen are, like normal cells, positive for ␤ 1 and9EG7, an antibody that reacts with the activated form of ␤ 1 38 (Figure 7 ), suggesting no effective ␤ 1 ablation. The latter data are consistent with difficulties previously encountered with ablation of ␤ 1 integrin in adult endothelial cells. 50 By contrast, Ms or F4/80 ϩ cells in the BM and the great majority of those in the spleen are ablated for ␤ 1 integrin. However, despite phenotypic appearances and depending on the signals they receive from their MEs, it is possible that the Ms are functionally different between these 2 tissues as previously shown for other tissues. 51 Nevertheless, it is doubtful that only the functional impairment of ␤ 1 ⌬/⌬ macrophages can explain the severe phenotype in ␤ 1 ⌬/⌬ spleens, as all classes of progenitors were affected. Furthermore, the functional role of Ms in proliferation/ maturation/enucleation of erythroid cells has not been fully elucidated, and controversial information is currently available regarding the molecular interactions between erythroid cells and Ms (ie, ICAM-4/␣ v ␤ 3 ). 52 Although many of the maturational defects have been cell-intrinsic (glucocorticoid receptor, thyroid receptor, ␤ 1 integrin), the specific interactions of these structures with ME cells or their effects on apoptosis pathways specifically activated in spleen in erythroid stress have been unclear.
Although progenitor defects in spleen quickly recovered in PHZ-treated ␣ 4 ⌬/⌬ mice, defects on terminally differentiated cells were present in both ␣ 4 -and ␤ 1 -deficient animals. Because the differentiation defects were similar in ␣ 4 ⌬/⌬ and ␤ 1 ⌬/⌬ mice, it is possible that interactions of both ␣ 4 and ␣ 5 through fibronectin or the interaction of ␣ 4 with both fibronectin and Ms are needed for efficient terminal erythroid differentiation. It is tempting to speculate that the effect in ␤ 1 ⌬/⌬ mice is a combination of absent ␣ 5 together with hypofunctional ␣ 4 , compromising adhesive interactions with both fibronectin and Ms in spleen. The presence of ␣ 4 ␤ 7 did not seem to provide any protective effect in ␤ 1 ⌬/⌬ mice. It is of interest that, despite prior implications of VCAM-1, 5 there was absence of differentiation defects in VCAM-1 ⌬/⌬ mice in our experiments ( Figure 6 ) that were consistent with experiments in fetal liver, in which the effects of VCAM-1 were dissociated from those of ␣ 4 ␤ 1 . 53 Moreover, using K562 cells as a model, it was shown that prolonged engagement to fibronectin throughVLA 5 (␣ 5 ␤ 1 ) triggered the induction of ␣ 4 in K562 cells (normally lacking ␣4) and the up-regulated ␣ 4 influenced erythroid differentiation by activating p38, an effect blocked by the RGD peptide. 11 Thus, the weight of evidence from previous and present data seems to support the notion that, at least in adults, ␣ 4 ␤ 1 interactions (with fibronectin or other partners) may be important for influencing terminal erythroid differentiation, probably within the context of EI, and may act in parallel or in cooperation with ␣ v integrins (interacting with ICAM4 and VLA4 on erythroid cells). 3 However, further studies are needed to clarify some of these issues.
Transplanted mice reconstituted with ␤ 1 ⌬/⌬ cells had a somewhat better erythroid response (Figure 4 ), suggesting that the stroma in the spleens of transplanted mice may have contributed to this. A cellular candidate of host origin that might have made a difference in transplanted animals is the F4/80 ϩ Ms in the spleen. Although the total number of F4/80 ϩ cells was not significantly different in nontransplanted versus transplanted animals, the proportion of ␤ 1 ϩ F4/80 ϩ cells was higher (23% vs Ͻ 10% in ␤ 1 ⌬/⌬ ) in transplanted animals, indicating incomplete reconstitution of M population by donor cells. Thus, the presence of ␤ 1 ϩ Ms (ie, ␣ v ␤ 1 ϩ ) could engage ␤ 1 ⌬/⌬ erythroid cells through ICAM-4 3 or through other undefined ways to promote erythroid expansion and terminal maturation. Intrinsic functional defects in ␤ 1 ⌬/⌬ Ms are also possible. In this context, it was recently noted that, using Lysozyme M-mediated ablation of ␤ 1 in Ms, ␤ 1 integrin is important for M maturation, as F-actin assembly in these cells was impaired through diminished Rac expression. 54 A similar defect in EMP null Ms led to failure of enucleation in erythroid cells. 6 In conclusion, our data evaluating stress erythropoiesis in 3 genetically deficient animals (␤ 1 conditional, ␣ 4 , and VCAM-1 with Tie-2Cre-mediated ablation) redefine the functional role of ␣ 5 and ␣ 4 integrins in this process and their distinctive interactions in BM versus spleen.
